CHAPTERS
- 0:00 – 16:20
Defining Pain: Nociception, Emotion, And The Brain’s Construction
Huberman introduces Dr. Sean Mackey and asks what pain is. Mackey frames pain as a complex, subjective, and highly individual experience that is both sensory and emotional, distinct from raw nociceptive signals. He emphasizes the societal burden of chronic pain and the need to rebuild public understanding from the ground up.
- •Pain is a subjective experience that protects us from injury but becomes pathological when chronic.
- •Nociceptors detect temperature, pressure, and chemical changes and send A-delta (fast, sharp) and C-fiber (slow, dull) signals.
- •Nociception is not pain; pain arises when these signals are integrated with emotion, cognition, and memory in the brain.
- •The outdated one-to-one biomedical model (stimulus = pain) persists and fuels misunderstanding and stigma.
- •People project their own pain experience onto others, making invisible conditions like fibromyalgia especially invalidated.
- 16:20 – 34:50
Where Pain Lives In The Brain And How Drugs Modulate It
They explore whether there is a ‘pain center’ in the brain and discuss the distributed networks involved. Mackey explains the shift away from a simple ‘pain matrix’, the emergence of brain-based pain biomarkers, and how common medications like NSAIDs, acetaminophen, and aspirin work at peripheral and central levels.
- •No single ‘pain center’; pain involves distributed networks (insula, cingulate, amygdala, thalamus, cortex).
- •Brain-based biomarkers show somewhat conserved patterns across people but with individual variation.
- •NSAIDs are anti-inflammatory/anti-hyperalgesic, not pure analgesics; they reduce sensitization after injury.
- •Acetaminophen acts more centrally and lacks NSAID GI/renal risks but has liver toxicity above ~4 g/day.
- •Aspirin is both an anti-platelet (low dose) and anti-inflammatory (higher dose), but its preventive use is now age- and risk-specific.
- 34:50 – 51:40
Balancing Pain Relief With Healing, Side Effects, And Individual Differences
Discussion turns to when and how aggressively to treat pain, given inflammation’s role in healing. Mackey outlines evolving evidence that NSAIDs may slow fracture and tissue repair, yet can be indispensable for allowing sleep and function. They cover dosing, rotation between ibuprofen/naproxen, GI and cardiac risks, and the complexity of making individualized tradeoffs.
- •Threshold for pharmacologic treatment: when pain meaningfully impairs sleep, daily functioning, or quality of life.
- •Evidence suggests NSAIDs may delay some healing (fractures, joint replacements), so many surgeons limit their use post-op.
- •There is large individual variability in response to ibuprofen vs. naproxen; trial and error is appropriate.
- •NSAIDs must be taken with food and adequate fluids; people with GI, kidney, or heart disease need medical guidance.
- •Acetaminophen is gentler on the GI tract but requires strict attention to total daily dose and alcohol use.
- 51:40 – 1:06:20
Spinal ‘Gates’, Mechanical Modulation, And Heat/Cold Analgesia
Mackey explains Melzack and Wall’s gate control theory and how rubbing, shaking, or TENS units reduce pain via spinal cord modulation. They then dissect the roles of cold and heat in acute and chronic injuries and raise questions about deliberate cold exposure and cross-modal pain thresholds.
- •Touch fibers (A-beta) activated by rubbing, shaking, or water flow inhibit nociceptive input at the spinal level.
- •Descending pathways from the brain also modulate spinal nociceptive processing (neuromodulation).
- •TENS devices exploit touch fiber activation to close the ‘gate’ to pain signals.
- •Cold reduces inflammatory mediator release and slows nerve conduction, while heat increases blood flow and relaxes tissue.
- •Typical heuristic: cold for the first ~48 hours post-injury, heat later—yet individual preference and response matter.
- 1:06:20 – 1:18:20
Pain Thresholds, Gender Differences, And The Role Of Expectation
They define pain threshold and unpack sex differences research, stressing the danger of overinterpreting small average group differences. Mackey details how anxiety, beliefs, prior trauma, and even experimenter characteristics (e.g., attractive researcher) change pain perception. He touches on exercise and cognitive strategies for modulating thresholds.
- •Pain threshold = intensity at which a stimulus first becomes painful, not merely hot or cold.
- •On average, women show slightly lower thresholds for certain modalities (e.g., heat), but distributions overlap heavily.
- •Individual variability within each sex is far larger than average sex differences; people are not averages.
- •Anxiety reliably increases pain; expectations and prior experiences powerfully shape perception.
- •Attention, reappraisal, and physical training (exercise/movement) can, over time, raise effective pain thresholds.
- 1:18:20 – 1:29:40
Conditioned Pain Modulation, Swearing, And The Power Of Context
Mackey describes ‘pain inhibits pain’ phenomena (diffuse noxious inhibitory control/conditioned pain modulation) and how a separate painful stimulus can dampen perception of another. They discuss swearing as an acute pain reducer, early-life responses to kids’ pain, and how maladaptive social responses may shape adult pain processing.
- •Conditioned pain modulation: a distant painful stimulus engages brainstem circuits that send descending inhibition to spinal cord.
- •This explains folk practices like stomping on a foot when an arm hurts; not recommended but mechanistically real.
- •Swearing during acute pain has been experimentally shown to reduce pain more than neutral vocalizations.
- •Parents’ reactions (minimizing, invalidating, or catastrophizing) likely shape children’s later pain responses and coping.
- •In several chronic pain conditions (e.g., fibromyalgia), conditioned pain modulation appears impaired.
- 1:29:40 – 1:42:50
Mindfulness, Acceptance, And Cognitive Reframing As Pain Tools
The conversation pivots to top-down approaches: distraction versus ‘meeting’ pain via mindfulness and cognitive techniques. Mackey differentiates attentional distraction from non-judgmental awareness and active cognitive reframing, noting they rely on distinct neural circuits. He underscores the strong evidence base for MBSR and CBT in pain, anxiety, and depression.
- •Distraction (attentionally demanding tasks) engages prefrontal and cingulate circuits and can significantly reduce pain.
- •Mindfulness-based stress reduction (MBSR) teaches non-judgmental awareness and acceptance of pain; effective across multiple conditions.
- •Cognitive behavioral therapy targets beliefs and appraisals (e.g., ‘this pain is damaging me’) to reduce threat and disability.
- •Different psychological strategies recruit different brain networks, suggesting individualized matching may optimize benefit.
- •Mind-body tools are low-risk and widely applicable; Mackey advocates broader deployment (e.g., in schools).
- 1:42:50 – 2:01:40
Hurt Versus Harm, Chronic Pain, And Emotional Pain Equivalence
Mackey introduces the crucial hurt vs. harm distinction with a vivid tennis player case and explains its centrality in chronic pain management. He rejects artificial splits between physical and psychological pain, arguing for treating pain as a unified biopsychosocial phenomenon. They discuss anger, catastrophizing, and how pain clinics repurpose drugs from other specialties to target pain circuits.
- •Chronic pain is typically defined as pain persisting beyond tissue healing; ongoing hurt often no longer indicates harm.
- •Teaching patients that safe activity may hurt but is not damaging can restore function and reduce fear.
- •Mackey does not separate ‘psychological’ from ‘physical’ pain clinically; all pain reflects brain-body interaction.
- •Anger (especially suppressed ‘anger in’) and catastrophizing strongly predict worse pain and poorer outcomes.
- •Most pain drugs are off-label borrowings (antidepressants, anti-seizure meds, antiarrhythmics) targeting ion channels and neuromodulators.
- 2:01:40 – 2:24:40
Nutrition, Gut Pain, Food Sensitivities, And Visceral/Somatic Convergence
They delve into visceral pain (e.g., abdominal, pelvic, cardiac) and how it differs from localized somatic pain, including referred pain phenomena. Mackey shares his own post-food-poisoning onion sensitivity and the difficulty of identifying delayed food triggers. They highlight elimination-style experiments, the possible role of microbiome and immune sensitization, and the emerging public health concern around adult-onset food reactions.
- •Visceral pain has large, diffuse receptive fields, leading to poorly localized sensations (e.g., ‘my whole stomach hurts’).
- •Viscerosomatic convergence in the spinal cord causes referred pain (e.g., heart attack to left arm, diaphragm irritation to shoulder).
- •Post-infectious changes can sensitize the gut to specific food antigens; Mackey developed severe onion-family pain after food poisoning.
- •Delayed onset (e.g., pain persisting for two weeks after exposure) makes trigger identification difficult without structured elimination.
- •Allergists report seeing more adult-onset food-related pain/immune issues, raising public health questions.
- 2:24:40 – 2:37:50
Love, Reward Circuits, And ‘Analgesia By Relationship’
Mackey recounts a study with Art Aron on early romantic love as an analgesic. Participants viewed photos of their beloved versus an attractive acquaintance while receiving painful stimuli and during a cognitive distraction task. Love and distraction both reduced pain but activated distinct neural systems, and early brain responses even predicted later relationship strength.
- •Newly-in-love individuals thinking about their partner showed robust pain reductions, comparable to distraction conditions.
- •Love-driven analgesia correlated with activity in reward and descending control structures (nucleus accumbens, caudate, insula, substantia nigra).
- •Distraction-driven analgesia recruited classic attentional networks in prefrontal/cingulate cortex.
- •Degree of passionate love (measured by standardized scales) predicted magnitude of analgesia.
- •Brain signals during love-viewing were associated with relationship strength one year later, in this small sample.
- 2:37:50 – 2:59:40
Endogenous Opioids, Prescription Opioids, And The Nuanced Reality Of The Crisis
They move into endogenous opioids and exogenous drugs like morphine, oxycodone, and fentanyl. Mackey describes his stance as ‘pro-patient,’ having seen opioids both transform and destroy lives. He dissects the opioid crisis narrative: overprescribing, poor physician education, bad actors vs. well-intentioned doctors, and how cutting patients off drove many toward illicit fentanyl and heroin.
- •Enkephalins and endorphins are endogenous opioids; exogenous opioids primarily act on the same receptor systems in brain, spinal cord, and periphery.
- •Mackey distinguishes three physician groups: right-thing/right-reasons (majority), wrong-thing/right-reasons (misled, undertrained), wrong-thing/wrong-reasons (pill mills).
- •Public policy and media often focused on the last group, creating broad fear and leading to abrupt tapering/abandonment of stable patients.
- •California data showed that cracking down on prescribers without support for patients doubled overdose deaths, as patients turned to street drugs.
- •Current overdose epidemic is largely driven by illicit fentanyls, not prescribed opioids, though careful prescribing and deprescribing remain essential.
- 2:59:40 – 3:14:00
Kratom, Cannabis, And Plant-Based Modulators Of Pain
Huberman raises kratom and cannabis as widely used but understudied pain tools. Mackey acknowledges kratom’s opioid-like properties and patient reports of using it to avoid stronger opioids, while warning about unknown purity, dosing, and overdose data. For cannabis, he notes limited experimental support for neuropathic pain, mixed clinical outcomes, and the need to reschedule it for rigorous study.
- •Kratom has opioidergic effects and some people report using it successfully to reduce or avoid opioids.
- •Overdose deaths involving kratom are increasing, often with polysubstance use; product quality and dosing are highly variable.
- •Mackey argues kratom likely warrants development as a prescribed drug after proper research rather than unregulated OTC use.
- •Cannabis shows modest benefit for neuropathic pain in lab settings but less clear benefit in broader clinical cohorts.
- •Scheduling cannabis as Schedule II (rather than I) would vastly ease research, clarify THC/CBD ratios, routes, and doses that are truly therapeutic.
- 3:14:00 – 3:31:20
Acupuncture, Chiropractic, PT/OT, And Multimodal Pain Rehabilitation
They survey non-pharmacologic modalities: acupuncture, chiropractic, physical and occupational therapy, and complementary/nutraceutical approaches. Acupuncture likely works via peripheral and central mechanisms but remains mechanistically opaque; chiropractic evidence is mixed and high-velocity neck manipulations carry rare but serious vascular risk. Mackey categorizes six major therapy domains for chronic pain and emphasizes coordinated, multimodal care.
- •Acupuncture has RCT support for some pain states and MRI evidence of distinct brain effects; mechanism may include adenosine and nerve modulation.
- •Patients should seek well-trained practitioners via trusted referrals and ask whether benefit is durable, not just transient.
- •Chiropractic manipulation shows mixed evidence; lower-velocity techniques may be safer, while high-velocity neck adjustments carry vertebral artery dissection risk.
- •Six major therapeutic domains: medications; procedures/nerve blocks; psychological/behavioral therapies; PT/OT; complementary/alternative approaches (e.g., acupuncture, nutraceuticals); and self-empowerment/education.
- •Optimal chronic pain care integrates multiple domains rather than relying on a single tool.
- 3:31:20 – 3:45:00
Supplements, Nutraceuticals, And Over-The-Counter Support For Pain
Mackey outlines several supplements with actual clinical data for pain, especially neuropathic pain, while cautioning that ‘natural’ does not equal risk-free. He highlights acetyl-L-carnitine, alpha-lipoic acid, vitamin C perioperatively, omega-3s, and emerging data on creatine. They stress checking interactions, especially around surgery, and the U.S.-specific regulatory context.
- •Acetyl-L-carnitine has RCTs showing improved nerve conduction in diabetic neuropathy (disease-modifying, not just symptomatic).
- •Alpha-lipoic acid is both an antioxidant and T-type calcium channel modulator with evidence for neuropathic pain but can have cardiac autonomic effects.
- •Vitamin C may reduce risk of certain post-op neuropathic pain syndromes when used prophylactically in nerve surgeries.
- •Omega-3 fish oils and possibly creatine have supportive pilot data for chronic pain and fibromyalgia.
- •Patients must consider side effects, dose, and drug–supplement interactions (especially bleeding risk before surgery) and involve their clinicians.
- 3:45:00
Pain Psychology, Digital Tools, And A National Strategy For Pain
In closing, Mackey details the role of pain psychology (CBT, MBSR, ACT, biofeedback) and describes his and Dr. Beth Darnall’s work on brief digital interventions like Empowered Relief and a large-scale digital health platform. He advocates for full implementation of the National Pain Strategy as his primary ‘wish’ for the field and urges listeners to engage policymakers.
- •Pain psychology focuses on skills training (reframing, relaxation, pacing, coping) rather than open-ended analysis.
- •Biofeedback helps patients downregulate sympathetic arousal, which otherwise tightens muscles, raises heart rate, and aggravates pain.
- •Empowered Relief condenses ~8 weeks of CBT content into a 2-hour class with validated benefits, ideal for broad dissemination.
- •Mackey’s digital platform collects multidimensional patient data and uses AI for prediction and personalized care, aiming to democratize access beyond major centers.
- •The National Pain Strategy is a bipartisan, comprehensive plan to transform pain education, care, and policy; it has been overshadowed by opioid guidelines and needs public pressure and legislative support for full implementation.
